Viewing StudyNCT06078696



Ignite Creation Date: 2024-05-06 @ 7:36 PM
Last Modification Date: 2024-10-26 @ 3:10 PM
Study NCT ID: NCT06078696
Status: RECRUITING
Last Update Posted: 2023-10-12
First Post: 2023-08-30

Brief Title: Siplizumab for Sickle Cell Disease Transplant
Sponsor: Markus Mapara
Organization: Columbia University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-09-28
Start Date Type: ACTUAL
Primary Completion Date: 2028-07
Primary Completion Date Type: ESTIMATED
Completion Date: 2029-07
Completion Date Type: ESTIMATED
First Submit Date: 2023-08-30
First Submit QC Date: October 9 2023
Study First Post Date: 2023-10-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-10-09
Last Update Post Date: 2023-10-12
Last Update Post Date Type: ACTUAL